Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of PMI will - over the next 2 Weeks and hit - by . In that time frame, PMI's share price is expected to range between - and -.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No Data | |||||||||||||||||||
PMI shares fell -4.28% in Wednesday, January 21, 2026's trading session, dropping from a previous close of $1.87 to move at $1.79. The stock demonstrated notable intraday movement (see PMI's key stats for a full breakdown), fluctuating between $1.69 and $1.86, a +10.06% trading range. While recent weeks have seen some volatility, PMI has managed to secure a -6.28% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 144.79K shares changing hands, 196.28K fewer than the previous session. This amounted to $259.18K in total market activity.
Will PMI Continue Its Trend?
According to analyst ratings and projections for PMI, Picard Medical, Inc. shares are anticipated to remain stable by -, potentially reaching - per share by January 1, 1970. Short-term technical indicators for PMI currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 21 negative trading days within the past 30 sessions. Based on the PMI stock forecast, now is not the best time to buy PMI stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on PMI covering social and institutional perspectives.
PMI Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into PMI's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 41.08% to 46.58%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 45.36%, suggests a neutral medium-term outlook. Insights into PMI's shareholder base show how institutional investors are positioning themselves during these momentum shifts

